Nuclear medicine firm UltraSPECT of Merrick, NY, has added a U.S. Food and Drug Administration (FDA)-cleared half-dose imaging feature to its Xpress.Cardiac half-time wide-beam reconstruction (WBR) image reconstruction product.
The new feature is designed to minimize radiation exposure to patients, while maximizing safety for patients and medical staff. With the addition, Xpress.Cardiac provides dose and acquisition time management, so rest/stress studies can be acquired using either half the radiopharmaceutical dose or half the scan time.
Related Reading
UltraSPECT nets FDA OK for software, June 2, 2009
UltraSPECT launches new SPECT package, May 1, 2009
Cardinal to sell UltraSPECT packages, April 2, 2008
UltraSPECT reaches U.S. milestone, August 1, 2007
UltraSPECT makes management changes, May 30, 2007
Copyright © 2009 AuntMinnie.com
